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Abstract 
Interest for in silico skin xenobiotic absorption models has been growing in the last years 
owing to the economic advantage of computer simulations over costly experimental 
procedures. This review presents a classification of the modelling categories reported in 
the scientific literature so far, discussing their capabilities and limitations. First, 
Quantitative Structure Permeability Relationships (QSPR) are presented and discussed, 
followed by Physiologically-Based Pharmacokinetic Models (PBPK). PBPK models include 
the compartmental approach, and modelling approaches based on the solution of the 
discretized diffusion equations in geometric representations of the skin in a Computational-
Fluid-Dynamics-like manner. The latter modelling category allows the user to represent 
relevant morphological elements of the skin (such as the stratum corneum, the hair 
follicles, and the pilosebaceous glands), and are expected to help with the development of 
efficient delivery of cosmetic products and medical drugs. The review highlights also 
several interesting directions for future research in the area of skin xenobiotic penetration 
made possible by the Computational-Fluid-Dynamics-like modelling category.  
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1. Introduction. 
The skin is the largest organ in the human body and also provides the primary interface to 
the external environment, an adult typically having a skin surface area of between 1.5 and 
2 m2 [1].  Maintaining healthy skin is therefore a very important aspect of maintaining 
health of the organism as a whole.   
Although the skin outer, epidermal layer, is mostly comprised of keratinised material which 
acts as a barrier against potentially disadvantageous substances, there are applications 
where it is important to ensure that the sub-layers of the skin structure (dermis and 
hypodermis) receive a sufficient amount of the xenobiotic at hand, which can either be 
provided internally, via the blood circulatory system, or externally via adsorption through 
the epidermis.  A significant potential advantage of topical application is that the active 
material can be provided in a local targeted fashion (c.f. with delivery via the circulatory 
system, which is non-specifically targeted and maintains a nominal concentration 
throughout the body).  
Nevertheless, there are significant challenges to optimising molecular transport across the 
skin, and to be more specific, across its outermost layer (the stratum corneum), which has 
the lowest permeability among the different sublayers of the skin owing to its specific 
morphology.  Understanding the kinetics of such transport processes in either an in vitro or 
an in vivo experiment is far from simple and as such, mathematical modelling and 
simulation becomes an attractive approach for nutrient, cosmetic and pharmaceutical 
design.  This is the context of the current review. 
We begin with a description of the modelling categories found in the literature in order of 
increasing detail, and follows with the specifics for the modelling of the sublayers that 
compose the skin. The document closes with a general summary of the current state-of-
the-art and future perspectives in the field. 
2. Evolution of xenobiotic absorption models (from QSPR to in silico 
physiologically-based pharmacokinetic (PBPK) modelling) 
Human skin exposure to chemicals can be intentional (this is case of cosmetics or medical 
drugs of topical application), or unintentional (industrial hazards derived from chemicals, 
pollutants, and cleaning products). Upon application on the skin, permeation occurs by 
passive diffusion through the successive skin sublayers and its appendages, e.g. hair 
follicles and pilosebaceous glands [2]. The hair follicle in particular constitutes a shortcut to 
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reach the deepest parts of the skin, having subsequently received considerable attention 
as of late [3–5]. The skin is formed of three main sublayers, i.e. the epidermis, the dermis, 
and the hypodermis, which lie on an adipose layer before muscular tissue. The epidermis 
lies in contact with the open air, and provides waterproof barrier as well as pigmentation. 
Two sublayers can be clearly differentiated in the epidermis: the stratum corneum, which 
constitutes the actual barrier given its low value of permeability, and the viable epidermis. 
The dermis is a complex combination of blood vessels, hair follicles, sebaceous glands, and 
fibroblasts. Collagen and elastin, substances which are crucial to a healthy skin, are 
synthesised in the dermis. Nerves are also found in the dermis. Moreover, its rich 
vascularisation makes the dermis the target for effective distribution of topically applied 
products to the rest of the organism via the circulatory system. The hypodermis consists of 
adipose and connective tissue, and is also highly vascularised. Clear differentiation of 
these layers, and their morphology and physical properties are crucial to the development 
of detailed PBPK modelling of the absorption of xenobiotics into the skin.  
The viable epidermis and dermis are commonly simplified in terms of modelling as 
homogeneous layers composed of approximately 40% water, 40% proteins, and 20% 
lipids [6,7]. Most research efforts however, focus on the stratum corneum, which is the 
outermost layer of the epidermis, and constitutes an effective barrier against penetration of 
alien substances, given its morphology. The stratum corneum is formed of two phases with 
different effects on the mass absorption rate: one formed mainly by keratinocytes, and the 
other by lipids. Most of the mass transfer occurs through the lipidic route given its greater 
permeability relative to the keratinocyte route. The complexity and relevance of the 
appropriate modelling of the stratum corneum is treated in Section 2.3.2 of this review.  
Skin appendages are weak points through which substances can diffuse rapidly, skipping 
the keratin barrier in the epidermis and reaching the blood stream (in the case of small 
molecules as is the case of most pollutants and cosmetics) and/or the lymphatic system 
(larger molecules as snake venom). Skin appendages have thus been intensively targeted 
in recent investigations as the primary route to accelerate drug and cosmetics 
administration, and as the sole route for big molecules to access the circulatory system [8].  
The pharmacokinetics of a xenobiotic substance after skin absorption is influenced by 
physiologic characteristics of the skin, the physico-chemical nature of the compound, and 
environmental effects, which must be considered from the modelling point of view so as to 
get accurate results. Thickness, hydration, and temperature are among the skin-specific 
factors, and have an effect on both the geometry of the different layers—so is the case of 
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the stratum corneum, which presents greater thickness and permeability as the moisture 
content grows, affecting the mass transfer rate. The permeability of the skin depends on 
the location in the body as well. Evidence provided in the literature establishes that the 
absorption rate and final concentration values of a particular compound in humans 
depends on the anatomical site considered [9], although the assumption of a constant 
overall permeability coefficient is often considered [10]. As for the effect of the 
environmental factors, Reifenrath and Spencer [11] concluded that wind, humidity, 
temperature, and vapour pressure have an effect on the quantity of product absorbed by 
the skin owing to loss of product to the environment through evaporation. A frequent 
source of error, for instance, when determining xenobiotic absorption rates in in vitro cell 
diffusion studies comes from covering the application site with an occlusive wrap to 
prevent loss of the compound towards the environment. Extra hydration of the stratum 
corneum may occur as a result as well, hence affecting the overall absorption rate [12]. 
Regarding the nature of the xenobiotic compound, the concentration of that particular 
chemical in the environment is usually a factor to be considered, whereas in the case of 
topical application the vehicle, i.e. the formulation used for topical application, is often 
considered as an infinite source. Diffusive properties, lipophilicity, polarity, etc. are also 
key to determine the final reach of the particular compound within the skin [13].  
The different approaches used to determine and use the above mentioned properties 
result in different types of models available in the scientific literature. The properties of a 
given compound and their effect in the permeability can simply be measured 
experimentally, subsequently fitted to a model, and used to predict the effect of new 
xenobiotics, i.e. this approach is known as a QSAR or QSPR models. Another option is to 
include basic data such as diffusion and partition coefficients into mechanistic models to 
obtain a more accurate description of the concentration depth-profiles of a given 
compound by solving the diffusion equations, the latter approach being called in silico 
PBPK models, which comprise the compartmental approach and models based on the 
application of numerical discretisation models [14] and those based on the solving of the 
diffusion equations.  QSAR models have been used for identification of potential hazards 
and risk assessment [15]. Lack of detail on the actual concentration depth-profile 
generated by the application of a xenobiotic component to the surface of the skin is a 
drawback, since QSPR models do not use a mechanistic approach to describe the 
xenobiotic penetration and also lack skin morphology details. On the other hand, holistic 
and fully transferrable models might be obtained when physics principles are applied to 
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calculate the values of the diffusion and partition coefficients which govern the mass 
transfer through the different layers of the skin, but in this case the validation process must 
be more comprehensive, with rigorous error assessments and providing space-time 
discretization confidence intervals. Moreover, in most cases the relation between the 
parameters needed to solve the diffusion equation and basic principles such as the radius 
of the molecules being implied are simply not available, and experimental correlations 
must be used instead. As a result, there is always a certain degree of dependency on 
experimental data in skin absorption modelling, although the latter reduces the 
experimental expenditure. The pursuit of ever increasing accuracy of numerical models 
must be the result therefore, of considering more complicated features of the skin 
morphology, i.e. accurate modelling of skin appendages, skin sublayers and 
vascularisation, and the pharmacokinetics of the product at hand, especially metabolism. 
The combination of all the above mentioned factors results in a complex mixture of 
physical phenomena, with simultaneous evaporation from the surface of the skin, sorption 
into the stratum corneum, with and without reversible or irreversible binding; and finally 
penetration into the viable epidermis, followed by either metabolism or transfer into the 
blood/lymph stream with subsequent distribution throughout the organism. Modelling is 
therefore, a valuable tool capable of simplifying the design process, and provide added 
value from conclusions that otherwise might be difficult to reach only via experimental 
work. 
Pharmacokinetics can therefore be investigated in vitro, i.e. using an experimental 
approach, and/or in silico, i.e. computer simulations. Both in vitro and in silico approaches 
are complementary, either because data from experiments have been used to develop the 
model, or to validate predictive models. Regarding in vitro, different approaches exist 
including empirical testing in bioengineered human tissue specifically grown for that 
purpose, in ex vivo skin samples obtained from living organisms by excision, or in animals 
(in vivo) [16,17]. Numerical modelling on the other hand, reduces the cost associated to 
experiments, and avoids the ethical conundrum of animal and human testing.  
The pharmacokinetics of a xenobiotic compound in the organism is divided in four stages: 
absorption (A), deposition (D), metabolism (M) and excretion (E), which are known in the 
literature with the acronym ADME. Numerous models have been reported in the literature 
dealing with absorption, which to date appear to be well validated against experimental 
data for some specific purposes [18]. While predictive pharmacokinetic absorption models  
are well established, those dealing with the rest of the aspects involved, namely 
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disposition, metabolism, excretion and others as proposed further down in this document 
(section 4) are less frequent [19], being the work reported by Y. Dacik et al. [20] a notable 
exception. In the latter, the authors introduced a term in the differential equation governing 
diffusion, to account for elimination via systemic circulation, with the objective of 
interpreting previously published microdialysis data. Among the three least explored 
aspects of pharmacokinetics, some studies regarding metabolism have been reported as 
of late, via QSAR models of data on metabolic routes obtained from the liver, the main 
organ responsible for metabolism.  The skin however, is also an important route of 
exposure, and therefore modelling the skin metabolism is key to predict and prevent the 
activity of harmful substances to the human body. Comprehensive, fully predictive in silico 
models of skin metabolism are yet to be developed, which opens an important alley in 
numerical modelling research. For deposition, only the model of Jones et al. [21] has been 
found.  
In silico models have gained in complexity over the past years/decades owing to ever 
increasing computational capacity and research ambitions. The evolution in complexity of 
in silico models for skin permeation towards predictive mechanistic models, capable of 
being used in any given scenario is shown in the graphical abstract. Fully predictive in 
silico models have not been attained yet however, and even state-of-the-art models such 
as that reported by Kattou et al. [22] rely on experimental correlations for the calculation of 
basic diffusion parameters. The figure shows the three main groups of pharmacokinetic 
models, namely QSPR, compartmental (skin divided in homogeneous compartments 
which match skin sublayers), and Computational-Fluid-Dynamics-like (shortened to CFD-
like in the remainder of this review) models. The latter two are commonly grouped as 
physiologically-based pharmacokinetic (PBPK) mechanistic models. Quantitative Structure 
Permeability Relationships (QSPR) first appeared to predict skin permeability of chemicals 
through the different layers which form the skin by using the molecular weight, the octanol-
water partition coefficient, and the solubility in water of a given component as independent 
variables (input data). The compartmental approach followed in complexity and introduced 
mass exchange between the layers, i.e. treated as separate compartments, at a rate 
determined by experimental data fittings. The common feature of these two model 
categories consists in treating each skin sublayer as a homogeneous medium with no 
distinct internal features [23,24]. Finally, CFD-like PBPK models have been introduced in 
an attempt to gain more detail in the description of pharmacokinetics and ultimately full 
versatility. A CFD-like PBPK modelling approach consists in reproducing the actual 
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geometry of the skin through a Computer Aided Design (CAD) software, and discretize the 
domain analogously to the modelling process followed in Computational Fluid Dynamics. 
The diffusion equations, or a combination of the latter and the Navier-Stokes equation, can 
be solved in the discretized domain to provide a more realistic visualization of the 
xenobiotic absorption. CFD-like models still rely, however, on experimental data of the 
diffusion and partition coefficients.  These models are therefore, useful to provide insight 
on some specifics of the problem, such as concentration depth-profiles, which would be 
otherwise difficult to get using experimental techniques. Full validation of specific purpose 
CFD-like models to describe any scenario other than that used to obtain basic mass 
transfer quantities has not been achieved so far however, limiting the application range, 
and making it necessary to complement the simulations with costly, or directly not 
available, experimental data. The following subsections provide further detail on the above 
mentioned in silico modelling approaches found in the literature, with the intention of 
reinforcing the need for the improvements proposed in section 4 as future work.    
2.1. Quantitative Structure Permeability Relationships (QSPR models) 
QSPR models are regression models frequently used in chemistry and biology to 
determine hazards posed by substances used in industry. Being based on regression of 
data obtained experimentally from in vitro assays at guaranteed steady-state conditions, 
QSPR models are restricted to the application being considered, and cannot be 
extrapolated to other conditions or simply to describe particular features of the skin 
described further down in this document, such as the appendageal shortcut. QSPR 
models aim on the other hand, to obtain accurate predictions of the permeability of the skin 
to a given substance, and thus constitute a useful tool for risk assessment. The model 
provided by Potts and Guy for instance has been recently used to evaluate the extension 
of the Threshold of Toxicological Concern (TTC) guidelines issued by the European Union 
[25–27]. They have also been used in the frame of the European Union COSMOS project, 
which aims to study the toxicity of cosmetic products. The input data (independent 
variables) to QSPR models are the measurements of the solubility in lipids, the partition 
coefficients and the molecular weight. Measuring solubility in lipids presents some 
experimental difficulties however, and surrogates are often sought, although providing a 
source of error (octanol is a common surrogate). The partition coefficients between the 
vehicle and the lipid are necessary to determine the concentration of the xenobiotic 
component at the outermost part of the stratum corneum, given the concentration in the 
vehicle. Once the permeability is established, the next step in the development of the 
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model is the application of the diffusion laws to obtain the mass transfer rate, total amount 
of substance being absorbed, etc., thus assessing the penetration potential of a given 
substance and the related hazards. The solute transport through the skin under steady-
state conditions can be calculated by integrating Fick’s first law, which allows for the 
calculation of the maximum flux. The integrated expression for the first Fick’s law gives the 
total amount of substance absorbed by the skin as a function of time and depth into the 
skin. Immediately after the application of the topical solution, there is, however, a lag time 
which varies considerably with the solute size—from 0.5 h for the permeation of water 
through the stratum corneum to hundreds or thousands of hours for larger solutes. 
The value of the maximum flux should however be corrected depending on the 
characteristics of a given xenobiotic. The European Commission has issued 
recommended values of the percentage of absorption rate in order to set guidelines for risk 
assessment policies. A value of 10% is used in case of solutes with a molecular weight 
greater than 500 Da and octanol-water partition coefficient smaller than -1 or higher than 
4, otherwise 100% of the maximum flux applies [28]. Considering that the vehicle can be 
approximated to an infinite source, the maximum flux is the result of multiplying the 
permeability coefficient and the solubility of the xenobiotic. 
QSAR models have been reported to obtain accurate calculations of the permeability of a 
number of substances via in vitro experimentation, being a widespread assumption that 
the stratum corneum behaves as a homogeneous layer. Details on the morphology of the 
stratum corneum are neglected, and thus, the quantification of the relative importance 
between the three different absorption routes within the stratum corneum (intracellular, 
lipidic, and appendageal) cannot be assessed, which might result in errors and lack of 
useful knowledge as to how skin appendages facilitate the penetration of large molecules. 
Another common assumption is that the resistance to skin absorption comes only from the 
stratum corneum, neglecting the resistance posed by the viable epidermis and upper 
avascular dermis, and possibly resulting in an over-prediction of the solute concentration 
reached in the highly vascularised layers of the skin. 
A comprehensive amount of information related to experimental data on permeation 
coefficients of hazardous substances has been gathered in data bases, although they 
present significant variations owed to a number of factors related to the subject or to 
specific conditions of the experiment. Some of these data bases published in the literature 
in the last three decades are summarised in Table 1. 
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Consequently, being the result of experimental data fittings, QSPR models do not 
constitute mechanistic tools to be validated against other experimental data sets obtained 
a posteriori, and therefore use them as predictive tools. QSPR models do not describe any 
particularity of the skin morphology either, losing their applicability to relevant cases such 
as the use of the appendageal route as a shortcut or skin metabolism. Some QSPR 
models are, thus black box models with limited application. That is the case of those 
models based on statistical learning approaches such as the k-nearest neighbour model 
[41]. These need to be catalogued and curated, highlighting the exact conditions of the in 
vitro procedures, in order to constitute a source of information of the hazards related to a 
given substance. Overcome their limitations with the aid of mechanistic tools however, 
would result in a substantial gain of information useful for many purposes ranging from 
design to hazard prevention. Furthermore, QSPR models cannot be extrapolated to 
conditions other than those upon which the data have been obtained, and therefore they 
cannot be used as predictive tools with the potential of saving money and resources for 
experimentation. QSPR models are still needed though, to support mechanistic models by 
providing the values of the parameters needed to discretise and solve the diffusion 
equations. 
As for the quality of these models to represent the penetration of xenobiotic substances 
within the skin, some QSPR models present a high degree of variability, reflected in the 
poor correlation coefficients resulting from fitting the data from in vitro assays. The 
simplest QSPR models obtain the permeation coefficient from the linear regression of 
basic structural descriptors, namely the molecular size (denoted by the molecular volume 
or the molecular weight) and the hydrophobicity (expressed by the octanol-water partition 
coefficient), although others utilise complex parameters such as quantum chemical 
indices.  
Table 2 presents a summary of several QSPR models with their correlation coefficients in 
order to measure the goodness of the fitting. The models of Potts and Guy [26,27], Mass 
and Cronin [42], and Magnusson et al. [39] are obtained using only the hydrophobicity and 
the molecular size and present correlation coefficients which range from 0.670 to 0.847. 
The model of Basak et al. [43] considers more than two descriptors, thus taking into 
account more complex molecular morphology aspects, although the goodness of the fitting 
does not necessarily improve with respect to the other models. This variability in the 
results needs to be taken into account when considering mechanistic models which use 
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QSPR models as a source of diffusion-related data so as to consider potential prediction 
errors. 
2.2. Compartmental PBPK models 
In the compartmental approach, concentration values are obtained by solving linearized 
diffusion equations of each compartment, which results in good economy of computational 
resources. These models consider each layer of the skin as a separate compartment with 
homogeneous properties. Compartmental models give, as a result, a single value of the 
xenobiotic concentration for each compartment, i.e. one compartment per skin sublayer. 
Although these models do not give a concentration depth-profile as a function of the depth 
in each compartment, they can be considered as an approximate attempt to provide a 
description of the concentration depth-profiles caused by the absorption of a xenobiotic 
component within the skin if one considers the whole assemble of compartments. In the 
limit, an infinite number of compartments would provide a well described and smooth 
concentration depth-profile.  
Each layer has therefore, an associated mass-balance ordinary differential equation in 
order to represent the movement of the chemical in and out of the compartment, resulting 
in an acceptable approximation of the concentration reached in the target layer or the 
systemic circulation. Generalisation of the compartmental model to any number of layers 
was introduced by Anissimov, who determined that the mass transfer rate constants 
between the different compartments can be expressed as a function of the diffusion time 
[44]. 
Compartmental models present thus an approximation to the concentration depth-profiles 
found and focus on the calculation of the mass transfer rate between layers, contrarily to 
previously discussed QSAR models, the objective of which is the calculation of 
permeability by fitting experimental data, with no solving of the diffusion equations. Extra 
compartments can be added to these models in order to account for storage of a given 
chemical into the skin and volatilisation of the component after topical application. 
Compartmental models are useful to represent the latter features, which would otherwise 
result in excessive computational load when represented in QSPR and PBPK models [45]. 
The complexity of compartmental models lies therefore, in determining the number of 
compartments needed to describe each application with an acceptable degree of 
accuracy. Simple compartmental models were limited to the study of the mass exchange 
between two compartments, namely the low permeability stratum corneum, and a high 
permeability second compartment which represents the viable epidermis and the upper 
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avascular dermis [46,47]. More complex models, featuring up to five compartments in a 
cascade disposition have been reported in the literature, too, in order to get a more 
accurate prediction of xenobiotic concentration at the target layer [48,49]. 
2.3. Computational-Fluid-Dynamics-like PBPK models 
PBPK models follow in complexity and, contrarily to the previous categories, are based on 
the inclusion of the physiological characteristics of the skin such as the depth of each layer 
to solve the diffusion equations [50]. The spatial dependence of the concentration is 
therefore represented instead of considering separate black-box compartments 
characterised by a constant value of the concentration. The diffusion equation can be 
solved analytically upon some assumptions or numerically by means of commercial or 
open codes based on finite differences, finite element methods, or finite volume methods. 
CFD-like PBPK models aim therefore to provide a detailed description of the concentration 
depth-profile within each skin sublayer. CFD-like PBPK models, however, are often 
supported by experimental data sets to fix the values of the mass transfer parameters—
through QSPR models previously developed for instance—and therefore, their field of use 
are often limited to the extent of the in vitro assays used to develop those QSPR models. 
Their capability to be extrapolated to describe any modelling scenario remains limited and 
depends on the input data to the model and ulterior validation against specific-purpose 
data. CFD-like models feature thus, the mathematics needed to reach an accurate 
description of the diffusion process, with more physiological detail than the compartmental 
models described in section 2.2. To gain accuracy, CFD-like PBPK models need to be 
complemented with a description of the skin geometry and specifics such as appendages 
or distribution of blood vessels. Today, research efforts are directed towards the 
development of polyvalent models capable of being applied to any potential scenario, as 
well of including both further pharmacokinetic features such as metabolic routes and 
excretion, and morphology specifics of the skin such as hair follicles and pilosebaceous 
glands. A schematic of the structure of a QSPR-supported CFD-like PBPK approach is 
described in Figure 1. The flow of information begins with the fitting of experimental data to 
calculate the parameters needed to solve the diffusion equations, and the morphology of 
the skin sublayers considered in the model. The output consists in the concentration 
depth-profiles, the accuracy of which increases with the degree of detail of the morphology 
data introduced in the model and the quality of the QSPR fitting. Data on the validation of 
PBPK models in the literature are nonetheless scarce. Kattou et al. [22] reported a 
comparison between their PBPK model and the experimental data of Otberg et al. [51], 
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who carried out in vivo assays in which a solution with ethanol and propylene glycol 
containing 2.5% caffeine was topically applied to the chest of six volunteers. The hair 
follicles were blocked using wax, and the concentration of caffeine in the blood was 
measured by taking blood samples from the volunteers. In the simulations, only the 
propylene glycol was considered for simplification. The comparison between in silico and 
in vitro series of data with and without hair follicle blocking shows good agreement, 
providing confidence in this modelling category. The experimental data show a high 
degree of variability attributed to the particular characteristics of the individuals from which 
data are sampled though, but generally speaking, the order of magnitude is the similar in 
both data series. An offset between the in vitro and the in silico concentration peak times is 
observed, which appears delayed in the case of the simulations. With these results in mind 
and in order to increase the accuracy of the model, the next step in its development might 
well be the inclusion of metabolic routes, i.e. by means of the introduction of mass source 
terms in the discretised equations, to represent the generation/consumption of substances 
derived from the interaction between substances already present in the skin and a given 
xenobiotic. 
The model of Kattou et al. [22] focuses on both the epidermis (considering the stratum 
corneum and the viable epidermis) and the dermis, for which the mathematical terms 
describing convective transport are defined so as to accommodate the diffusion within the 
systemic circulation. The main transport mechanism in the stratum corneum and the viable 
epidermis is passive diffusion and therefore, the convective term is omitted in the 
mathematical description of these skin sublayers. The model includes three possible 
penetration pathways: the route through the lipids in the stratum corneum and the 
subsequent viable epidermis and dermis, the intracellular route through the low 
permeability corneocytes which form the stratum corneum (the structural description of the 
stratum corneum by means of the bricks and mortar model is included in the following 
subsection 2.3.2), and through the hair follicle, which constitutes a shortcut for xenobiotic 
penetration into the highly vascularised dermis. As boundary conditions, Kattou et al. [22] 
considered a 2D geometry with zero flux outer boundaries, which means no loss of active 
component through evaporation to the environment and overall unidirectional diffusion 
towards the dermis, the latter being a small source of error when a sufficient portion of skin 
is considered. A structured grid was obtained by discretisation of the 2D domain. The 
method of lines was applied to simplify the governing partial differential equations into 
linear differential equations [52]. The simplifications introduced in this model were the 
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suppression of the bending of the stratum corneum in the region nearby the hair follicle 
and the funnel-shaped infundibulum [53]. 
Considering that CFD-like PBPK models rely on the morphological description of the skin 
layers, a detailed description of the modelling specifics of each layer is included in the 
following subsections, e.g. vehicle, stratum corneum, viable epidermis, and appendages, 
in order to provide the reader with an idea of the reach of state-of-the-art modelling and 
the potential gaps which arise. 
2.3.1. Modelling of diffusion through the vehicle 
In some cases, the vehicle can be approximated as an infinite source of the xenobiotic 
studied, and so has been implemented in the boundary conditions in some PBPK models 
reported in the literature. In the in silico calculation presented by Chen et al. [13] for 
instance, the vehicle is simulated as an infinite source with a constant concentration of the 
active component, with a thickness of 0.7 mm. The approximation of an infinite source is 
appropriate provided its initial concentration is far above the saturation point and that 
concentration in the vehicle during the experimental period (~30 min) does not drop below 
the solubility value. This opens the question as to what can occur if a vehicle layer with a 
finite thickness and active component concentration is implemented. 
New directions in the modelling of the vehicle (also discussed in section 4) would consist 
in including other specific components that have been as carefully selected as the 
drug/chemical itself. These added components might help with improving the delivery, 
stability or activity of the active ingredient, or simply by facilitating the delivery via an 
increase in moisture content in the skin. Commonly used components include surfactants 
and penetration enhancers, which increase the diffusion coefficient of the xenobiotic 
component by disrupting the barrier which constitutes the stratum corneum. Penetration 
enhancers may also improve the partitioning between the formulation and the stratum 
corneum, or decrease the skin thickness to facilitate permeation [54]. 
2.3.2. Modelling of the stratum corneum. The ‘bricks and mortar’ approach 
The stratum corneum represents the main barrier to xenobiotic penetration, and is 
therefore rate-limiting. Detailed description of its geometry and the three possible 
pathways through it (intracellular route through low permeability corneocytes, high 
permeability lipidic route, and appendageal shortcut) is necessary in order to attain small 
comparative errors between in vitro and in silico data. Lately-developed diffusive-based 
models have incorporated a detailed description of the morphology of the stratum corneum 
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known as the ‘brick and mortar’ model [55,56]. The stratum corneum is mainly formed of 
several consecutive layers of low permeability keratin cells named corneocytes, which 
result from the replacement of intracellular organelles by a compact proteinaceous 
cytoskeleton, and lipids. In the ‘bricks and mortar’ description, each corneocyte is treated 
as a block with near-zero permeability linked to the adjacent block through a lipidic gap 
where diffusion occurs, i.e. the mortar. The composition of the stratum corneum depends 
on the area of the anatomical location considered though, but on average is formed of 15–
25 layers of flattened, hexagonal corneocytes. Each corneocyte has an approximate 
diameter of 30–50 μm and a thickness which varies between 0.2–0.5 μm [57]. The mortar 
constitutes between 10% and 15% of the dry mass of the stratum corneum, and therefore, 
having a high proportion of water, it serves as the main channel for xenobiotic permeation. 
The implementation of a PBPK model featuring the geometry of the stratum corneum as a 
‘bricks and mortar’ zone can shed light on the relative importance of those three routes 
based on a number of factors such as hydration degree. In this direction, Naegel et al. and 
D. Feuchter et al. [58,59] developed a 3D computational model to account for the effect of 
the corneocyte geometry on the overall diffusion of xenobiotic components through the 
stratum corneum. The authors implemented corneocytes with, in increasing order of 
realism, ribbon, cuboid, and tetrakaidekahedral shapes based on previously reported 
literature data [60,61], reaching the conclusion that the morphology of the corneocytes 
plays a key role on the permeability of the stratum corneum. A tetrakaidekahedral 
corneocyte resulted in skin permeability that doubles that found for 2D ribbons. Their work 
has application in the understanding of skin diseases such as psoriasis, which affect the 
morphology of the stratum corneum, and thus, results in a change of skin permeability. 
The treatment of the stratum corneum as a heterogeneous layer due to the existence of 
both corneocytes and the lipidic gap implies a considerable computational effort. Muha et 
al. [62] developed in this regard a mathematical method to implement a homogeneous 
equivalent to the brick-and-mortar model.  
Common defining values of geometry and composition of the stratum corneum are 
provided by Johnson et al. [63] and Mitragoti et al [64]. Apart from the particular location in 
the body considered, the thickness of the stratum corneum presents a strong dependency 
on the hydration degree, varying from 52 μm to 16 μm upon low hydration, which affects 
the diffusion of any xenobiotic component strongly.  
To model the stratum corneum, the properties of the ‘bricks’ and the ‘mortar’ need to be 
established separately. In particular, the diffusion coefficient of a given component through 
15 
 
the corneocytes (intracellular route), and through the mortar (lipidic route), as well as the 
partition coefficients between the lipids and the corneocytes, need to be determined. 
Anisotropic diffusion in the lipids of the stratum corneum, which is caused by the 
composition which is formed by crystalline and liquid parts, is usually neglected in the 
models reported in the literature [65], which consider the lipid phase in the ‘bricks and 
mortar’ model as homogeneous, resulting in an approximation which has proved to be 
accurate enough. 
2.3.3. Modelling of appendageal route: The hair follicle 
The hair follicle can act as a shortcut for xenobiotic penetration when active, that is to say, 
sebum is being produced and the hair follicle is growing [66]. Skin appendages, i.e. hair 
follicles, have not been traditionally considered as penetration routes owing to the small 
proportion of area they occupy—approximately 0.1% [67]. Hair follicles possess high 
vascularization however, which makes them even more attractive to be used as a shortcut 
for xenobiotic administration. They also give as a result, higher area than initially thought 
owing to the fact that they reach deep into the dermis, increasing the actual area available 
for xenobiotic permeation. Hair follicles present also diffusion coefficients significantly 
higher than the stratum corneum, making the follicular route more interesting from the 
point of view of xenobiotic absorption than the rest of the skin surface [68]. Some studies 
consequently suggest that the follicular route is particularly favourable for hydrophilic and 
high molecular weight molecules, as well as in the case of drugs delivered by using 
particles, owing to the difficulty of these molecules to cross the stratum corneum [69]. In 
spite of those advantages, models of the follicular absorption route are scarce in the 
literature, being the reported models presented by Liu et al. [70], Bookout et al. [71], and 
Frum et al. [72] summarised in Table 3. Liu et al. [70] compared the penetration of caffeine 
in human skin blocking and without blocking hair follicles using two different methods 
including a compartmental model with first order absorption and elimination. Bookout et al. 
[71] also reported a compartmental model, an interesting feature of their model being the 
inclusion of parallel subcompartments to represent the hair follicles. These models 
highlight the importance of the follicular route in xenobiotic penetration, with the absorption 
from the stratum corneum showing an approximately 10 min delay while there was no 
delay for absorption from hair follicles. An interesting modelling approach is that of Radtke 
et al. [73] who presented an approach based on Brownian dynamics instead of solving 
diffusion equations.  
2.3.4 Modelling the transport through viable epidermis and dermis. 
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In terms of modelling both the viable epidermis and the dermis behave similarly, since they 
have almost identical multiphase compositions. The dermis consists of collagen and 
elastin fibres immersed in an aqueous matrix, with a thickness which depends on the 
anatomical location and reaches 4 mm at its maximum. The hair follicles and sweat glands 
are embedded within the dermal layer, and provide a fast route towards the rich 
vascularisation located in the transition between the epidermis and the dermis [74]. 
Relevant to mass transport and therefore to be accounted for, are also the presence of 
proteins where drugs can bind and small ramifications of the blood and lymphatic system 
which might be modelled as negative mass sources in the transport equation. Dermic 
blood vessels are concentrated in the upper 100–200 μm of the dermis, i.e. the papillary 
dermis, and decrease considerably in the lower part of the dermis, i.e. the reticular dermis. 
These aspects are also important in order to define areas of the computational domain 
where convection should be considered. The overall structure of the vessels consists of a 
dense aggregate of blood vessels running along the epidermal–dermal junction, a less 
dense plexus found much deeper in the lower (reticular) dermis, and connecting vessels 
that also connect to the hair follicles and sweat ducts [75].  
2.4. Experimental methods for model validation 
A brief description of experimental visualization techniques is given in this section so as to 
provide some information about the types of techniques that might be used for that 
purpose, with intention of not limiting the contents of this work to a purely numerical 
approach and also to provide some guidelines as to the type of data sources to be used 
for validation. Data obtained by in vivo/ex vivo studies and data sets from previous in silico 
methods can also be used for preliminary validation of skin permeation models. Ex vivo 
characterisation is usually combined with imaging methods as an effective method to use 
clinical waste for skin permeation studies, and thus avoiding ethical considerations. 
Sample preparation and preservation for ex vivo studies is critical, i.e. including removing 
the subcutaneous adipose tissue, and histological characterisation, and needs to be 
performed to determine the exact thickness and composition as a function of the location 
in the body. Pre- and post-examination integrity checks need to be performed as well to 
assess any damage and to ensure a reliable experimental basis to obtain good data [76]. 
Imaging techniques are commonly used to assess xenobiotic dermal penetration, allowing 
for the obtaining of concentration values in the receptor fluid. Among the available 
techniques, Dennerlein et al. used liquid chromatography linked with inductively coupled 
plasma-mass spectrometry (LC-ICP-MS), which allowed for the obtaining of the evolution 
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of concentrations over time [77]. Otberg et al [51], obtained similar data by applying a new 
surface ionization mass spectrometry (SI/MS) technique, and measured the intensity of 
transcutaneous permeation and the transient evolution of the concentration of caffeine in 
the blood stream. The authors focused on the effect of hair follicles on the permeation of 
aqueous caffeine solutions. Varnish-wax microdrops allowed the authors to modulate the 
access through the follicular route, establishing a comparison method to assess the effect 
of the hair follicle on the overall absorption rate. The predictive capability of the model 
reported by Chen et al. [13] was checked by comparison against data obtained in vivo 
after intentional exposure of human volunteers to 4-cyanophenol. Cleansing of remaining 
4-cyanophenol and excision followed, so as to obtain samples of the stratum corneum. 
Subsequent measurement of the concentration depth-profiles followed by using Fourier 
transform infrared spectroscopy (ATR-FTIR) were performed [78]. 
3. Conclusions 
This review summarises the most common approaches developed so far to model the 
pharmacokinetics of xenobiotic substances within human skin. Models are classified in 
three categories according to the level of detail with regard to the skin morphology: 
Quantitative Structure Permeability Relationships (QSPR) and Physiologically-Based 
PharmacoKinetics (PBPK), which comprises compartmental models and diffusions-based 
approaches. A considerable number of these models are available in the literature on the 
absorption characteristics of xenobiotic components (mostly QSPR and compartmental 
models), whereas models describing other aspects of the pharmacokinetic activity, namely 
deposition, metabolism and excretion (summarised in the literature with the acronym 
ADME), are still relatively scarce.  
An approach based on the discretization of the diffusion equations was used to consider 
specific morphological elements of the skin.  
QSPR models—also known in the literature as QSAR models—are the result of 
experimental fittings that relate the permeability of the skin to a given substance, i.e. 
usually considering only the stratum corneum, to parameters which define the size of the 
active principle and its solubility in lipids, among others. QSPR models offer an overall 
estimation of the penetration potential of the substance in study and thus, they constitute 
useful tools for risk assessment purposes. The absorption process is however treated as a 
black box, in which the physico-chemical characteristics of the compound are introduced 
and the model estimates a penetration potential and these models lack a detailed physical 
description of the skin morphology.  
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Compartmental models aim to close the gap of the loss of detail by introducing and solving 
linearized diffusion equations. This methodology consists in dividing the skin in different 
compartments, that is, one compartment per each skin sublayer with similar physico-
chemical characteristics. Each compartment is characterised by one simplified diffusion 
equation, which gives a constant value of concentration as a result. Compartmental 
models provide thus an estimation of the concentration in each of the layers which form 
the skin, as well as the transfer rate between compartments. Compartmental models 
represent a first estimation of the actual distribution of solvent within the skin, but lack 
detail since they do not take into account crucial morphology aspects of the skin, such as 
hair follicles and the pilosebaceous glands.  
To bridge this gap, Physiologically-Based PharmacoKinetic (PBPK) CFD-like models were 
developed. These models consider the morphology of the skin, e.g. the thickness of each 
sublayer, the distribution of blood vessels, etc., as they include a discretization of the 
computational domain in a similar manner to a Computational Fluid Dynamics. CFD-like 
PBPK models can therefore be used to include the morphology of the main barrier to 
xenobiotic penetration, i.e. the stratum corneum, through the inclusion of the ‘bricks and 
mortar’ approach, and other routes such as the follicular route, which is of high interest to 
the cosmetic industry and for drug delivery purposes since it has been experimentally 
proved as an effective shortcut to reach the highly vascularised dermis. CFD-like PBPK 
models also allow for insight on the different penetration routes (low permeability 
intracellular route, high permeability lipidic route, and appendageal route), establishing the 
relative importance between them as a function of the physico-chemical nature of the 
particular compound studied, mainly the size of the molecule, its lipophilicity, and its 
solubility in water. Although the increased degree of morphological detail, the capabilities 
of PBPK models have not been widely exploited as of yet.  
As a final conclusion, the modelling of xenobiotic penetration into human skin appears to 
be in an early stage of development. A view on the current panorama of the modelling of in 
silico xenobiotic absorption into human skin reveals itself as rather incomplete, with many 
of the models consisting in the fitting of gathered experimental data, i.e. these are known 
as QSPR models. The next step in complexity are compartmental models, which consist 
on the resolution of a set of linearized diffusion equations, giving specific constant 
concentration values in each layer of the skin (compartment) as a result. To date, both 
models present dependence to some extent, on experimental data obtained previously, 
whether on data constituting the basis to the obtaining of an experimental correlation in the 
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case of QSPR models, or on the obtaining of the basic parameters needed to solve the 
diffusion equation in the case of compartmental and CFD-like PBPK models or simply for 
validation purposes. The pathway towards comprehensive and fully predictive in silico 
models seems to include the use of software offering the user the flexibility to implement in 
those models characteristics not explored in the field as of yet, paving the way to a more 
accurate virtual representation of the skin and its behaviour.  
4. Future research directions. 
This section proposes different directions to expand the capabilities of CFD-like PBPK 
models by considering other key features that could provide a competitive advantage 
when designing products applied on the skin. These different potential research directions 
are summarised in Figure 2 and commented as follows: 
a) Effect of vehicle thickness, microstructure and physical properties on xenobiotic 
transfer. 
The capabilities of CFD-like PBPK models could be expanded by considering the 
microstructure of the vehicle and the slow release of active principles or the evolution of 
the vehicle properties while its solvent evaporates or diffuses into the skin. Furthermore 
the transfer of nano-particles through the skin to the blood, that is a potential major side 
effect of their use in cosmetics (e.g. TiO2 and ZnO2 in sunscreens [79, 80, 81]), could be 
included in the discretization of the diffusion equations. This could support the 
development of novel cosmetic formulations able to slow down or to stop the transfer of 
nanoparticle to the skin and prevent/limit their negative effects on the skin and on the 
body. 
b) The effect of skin hydration on the transfer of xenobiotics and on the skin 
microstructure  
Skin hydration causes the swelling of the corneocytes, significantly changing the geometry 
of the stratum corneum, and its permeability to the active principles found in a particular 
formulation, but also the diffusion of undesired xenobiotics (e.g. air pollution). Experimental 
evidence suggests that the swelling of the stratum corneum—the main barrier to 
xenobiotic penetration—is mainly due to the change in shape of the corneocytes, 
particularly in the direction perpendicular to the skin surface, resulting in a reduction of 
their aspect ratio. Bouwstra et al. [82] provide quantification of this phenomenon, and 
suggest that not all the corneocytes swell to the same extent, with those near the 
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outermost part of the stratum corneum showing less aspect ratio than those at deeper 
parts of the stratum corneum as a result. 
The change in morphology and composition of the stratum corneum owed to hydration 
results in the modification of the diffusion coefficient [83]. Owing to the moisture increase 
causing a reduction of the proportion of low-permeability keratine in the stratum corneum, 
there is an exponential increase on the diffusion coefficient with the moisture content. 
There is thus a combined effect of moisturization, with an increase of thickness of the 
stratum corneum on the one hand and an increase in the diffusion coefficient on the other. 
The former should result in hindered xenobiotic penetration owing to the increase in the 
thickness of the main barrier to penetration, whereas the latter should enhance it. The 
solving of the diffusion equations in a discretized geometry representing the skin should 
constitute a powerful tool for the analysis of this double effect.  
c) Modelling perspiration and its effects on xenobiotic transfer 
Skin perspiration consists in the secretion of sweat by the sweat glands, its transport 
through the pores toward the skin surface and the formation of a liquid layer at the surface 
of the skin. The effect of sweat secretion on the skin moisture content, on the delivery of 
actives and on the undesired influx of nanoparticles should be evaluated. If the sweat duct 
can act as a preferential path for xenobiotic ingress, then the effect of the outflow of sweat 
should play an important role in modulating the xenobiotic transfer into the skin. The 
modelling of this effect can be easily accomplished by adding mass source terms in the 
diffusion equations, defined only in the relevant computational cells.  
d) Introduction of metabolic pathways 
Metabolic reactions of the compounds absorbed in the human skin can also be modelled 
by adding mass source terms to the mass governing the diffusion within the skin layers. 
Those mass source terms are posed as a function of the reaction rate and account for the 
generation/consumption of components owing to chemical reactions. The addition of 
metabolic routes, which will potentially reduce comparison errors with experimental data or 
the deposition of xenobiotic substances by chemical binding to components which form the 
different layers of the skin [84]. Cutaneous metabolism of a chemical applied to the skin is 
difficult to differentiate in vivo from the systemic metabolism occurring mainly in the liver by 
analysing blood and excreta samples. In vitro approaches can provide accurate insight on 
the specifics of skin metabolism by isolating the skin from the metabolic activity in the rest 
of the body, providing a source of data for validation purposes. 
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LIST OF FIGURES 
 
Figure 1 This input/output schematic diagram of a sorption-only CFD-like PBPK model shows the 
data needed to run the model and the target output. The main difference with respect to the 
previously mentioned model categories is that, in this case, the physiology of the skin layers is also 
included, meaning that not only are the diffusion and partition coefficients used as an input, but 
also the geometric dimensions and morphology are fundamental to obtain a discretized 
representation of the skin. 
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Figure 2 Schematic view of future research directions and capabilities of the CFD-like PBPK 
modelling approach 
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Table 1 Summary of available databases with permeability coefficients available for QSPR 
models published in the scientific literature as of 2017. 
Author No. of partition 
coeff. (𝑲𝒑) 
values 
Molecular 
weight 
(𝑴𝒘) 
[g/mol] 
𝒍𝒐𝒈(𝑲𝒐𝒘) 
(𝑲𝒐𝒘 being 
the octanol-
water 
partition 
coeff.) 
 Further comments 
Brown et al. (2016) [29] 392 from 245 
compounds 
18–765 -6.8 to 7.6 Only from human skin and using water as 
the vehicle. 
Alves et al. (2015) [30] - - -4.85 to -0.94 Data from human and rodent skin 
samples. 185 and 96 compounds 
considered, respectively. 
Chen et al. (2013) [31] 71 from 35 
compounds 
- - Only from human skin and hydrophilic 
chemicals. 
Flynn (1990) [32] 97 from 94 
compounds 
18–765 -3 to 6 High variability owed to use of samples of 
various parts of the body, which affects 
skin composition and morphology. This 
database was revised, double-checked 
and expanded by Johnson et al. (1995) 
[33] and Degim et al. (1998) [34] 
Wilschut et al. (1995) 
[35] 
123 from 99 
compounds 
- - Various chemical classes considered 
including monoaromatic hydrocarbons, 
volatile halogenated hydrocarbons, 
phenols and steroids. Useful for industrial 
hazard evaluation, but lacking 
components used in pharmaceutical and 
cosmeceutical industries. 
Kirchner et al. (1997) 
[36] 
114 from 51 
compounds 
- - A number of results compiled in this 
database are not the result of in vitro 
experiments but from the application of 
the Guy and Potts correlation [26,27]. 
Patel et al. (2002) [37] 186 from 158 
compounds 
- - High diversity of compounds structure. 
Vecchia et al. (2003) 
[38] 
170 from 127 
compounds 
18–584 -3.1 to 4.6 - 
Magnusson et al. 
(2004) [39] 
- 18–765 -5.7 to 8.7 The database directly provides the values 
of the maximum flux. 
EDETOX (2004) [40] 4800 from 320 
compounds 
- - Considerable additional information 
(description of the skin samples, lag time, 
exposure time, etc. 
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Table 2 Summary of QSPR models based on linear regression and the quality of the fit 
Author Correlation coefficient (𝑹𝟐) Comment 
Potts and Guy (1992) 
[26,27] 
0.670 Hydrophobicity and molecule size as structural 
descriptors 
Moss and Cronin (2002) 
[42] 
0.820 Id. 
Magnusson et al (2004) 
[39] 
0.847 Id. 
Basak et al. (2007) [43] 0.67–0.87 Model including not only two structural descriptors but 
also shape descriptors and quantum chemical indices.  
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Table 3 Summary of relevant literature on hair follicle modelling 
Reference Method Conclusions 
Liu et al. [70] Wagner-Nelson method and 
compartmental with first order 
absorption and elimination. 
 Tenfold increase of 
absorption rate through 
follicles with respect to 
absorption rate through 
stratum corneum. 
 No absorption delay in 
follicles; whilst 10 min delay in 
the stratum corneum. 
Bookout et al. [71]  Enhanced PBPK model obtained with 
measurable parameters and featuring 
parallel layers representing the skin 
appendages 
 Improved predictions of 
chemical concentrations are 
obtained with the multi-
layered model rather than 
with the previous 
homogeneous model in which 
the present model is based.   
Frum et al. [72] Skin sandwich technique.   Above a critical value of 
octanol-water partition 
coefficient (𝐾𝑜𝑤), the relation 
between the % follicular 
contribution and the drug 
absorption rate depends on 
the lipophilicity. 
Kattou et al. [22]  Predictive model using open code.  Data with which the model is 
compared is not used to 
predict the diffusion 
parameters which define the 
model. 
 
 
 
 
